Aktiia was founded in Switzerland in May 2018 out of a passion to create the best tool for diagnosis and treatment of hypertension. Aktiia’s founders, Mattia Bertschi (CEO) and Josep Solà (CTO), previously contributed to research and development at CSEM, a prestigious Swiss research institute. For 15 years they worked day in and day out to understand the language of our heart signals and decode key markers to gain better insight into blood pressure. They built an incredible team of 14 employees and founded Aktiia to turn their years of pioneering work into a useful tool for people around the globe.
Aktiia’s technology combines common optical sensors and proprietary clinically tested algorithms to measure blood pressure at the wrist.
08.07.2025
Aktiia’s Hilo Band Is First FDA-Cleared Cuffless BP Monitor for OTC Use (startupticker.ch)
01.05.2025
Aktiia secures $42 million Series B funding and rebrands to Hilo (startupticker.ch)
27.11.2024
Development milestones to propel Medtechs to next step (startupticker.ch)
07.08.2024
Entering a new phase with experienced industry experts (startupticker.ch)
11.07.2024
Four new ventures set to shine within CSEM (startupticker.ch)
No Jobs
Aktiia, the Complete Blood Pressure Monitor
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Website:
www.aktiia.com
Headquarter:
Neuchatel
Foundation Date:
May 2018
Technology:
Sectors: